CTS received notification from Sanochemia Pharmazeutika AG of their intent to immediately discontinue production of Fluorognost HIV-1 IFA test kits routinely used for confirmation of HIV-1 antibody-reactive donations. Based on our current testing volume, CTS has sufficient HIV-1 IFA reagent inventory to continue performing this confirmatory test through the end of August 2019.
Check out the Communication page for the complete details on the updated IFA HIV-1 assay or by clicking the link: Communications
This is the first update to the original CTS communication distributed on July 6th. As previously co...
As an organization dedicated to the safety of the world’s blood and plasma supply, Creative Testing...
In 2016, the Procleix Panther instrument was introduced by Grifols in support of automated NAT ZIKA ...
CTS implement the Bio-Rad Geenius HIV 1/2 supplemental assay on Monday September 21, 2020. The newly...
We received an updated WNV package insert; please note the manufacturer and license number has been ...
The CTS Medical Advisory Board recently agreed upon a revision to our standard testing algorithm. Th...